MRC Confidence in Concept Fund

MRC Confidence in Concept Fund

The Tropical Infectious Disease Consortium is managing the MRC Confidence in Concept Award 2020 which can be allocated to individual projects that accelerate the transition from discovery science into therapeutic, diagnostic and vaccine development.  


The Tropical Infectious Disease Consortium (TIDC) has been awarded MRC Confidence in Concept (CiC) funding for 2020. TIDC is a strategic partnership between LSTM,  Public Health England (PHE), London School of Hygiene and Tropical Medicine (LSHTM) and the Jenner Institute, Oxford.   The award will allow the Consortium to support pump-priming projects, typically in the range of £50K, with the overarching ambition to  accelerate the transition from discovery science into therapeutic, diagnostic and vaccine development.”

‘The overarching aim of the consortium is to support preliminary work or feasibility studies which establish the viability of the approach and thereby accelerate the development of the solution’, says Giancarlo Biagini, Professor of Parasitology at LSTM, Senior Manager within the Consortium and The Centre for Drugs and Diagnostics (CDD).

‘Following receipt of CiC awards, we would expect the projects to be competitive for more substantive funding such as MRC DPFS awards’, 

Projects within the following categories will be eligible to apply:

• Diagnostics
• Therapeutics
• Vaccines
• Vector control tools
• Translational focussed Informatics
• Translational enabling technologies

Eligible projects should be at the stage where allocated funding by the Consortium would develop the approach to the next level where it would be capable of successfully applying to larger external translational funding sources. It is the objective of the Tropical Infectious Disease Consortium to create a critical mass necessary for UK researchers who are interested in translating their research into health benefits, which will support them in an increasingly competitive international market. The aim is to support a high number of scientifically excellent translational proposals.

Applications are required to have a Principal Investigator from one of the Consortium’s partner institutions.  The PI can be from any academic department and would typically be an academic and research active member of staff that meets the following criteria:

  • Contract duration longer than CiC project
  • MIN 4years PDRA experience
  • Previous experience/evidence in securing funding OR in research project leadership role (evidence required in application form)

PIs can submit multiple applications but only their top scoring project will be funded.

Applications that involve collaboration between more than one partner institution are encouraged. 

A weighting will be added to the GPA if the project involves collaborations with SMEs/Pharma, but these must be led by an eligible academic PI.